KCNQ4
KCNQ4 (potassium voltage-gated channel subfamily Q member 4, also known as Kv7.4 or DFNA2) is the pore-forming subunit of a voltage-gated potassium channel. It helps regulate the excitability of sensory cells in the cochlea and is important for normal hearing. Browse Assay Genie's current range of KCNQ4 research reagents below, or read on for the biology behind the target.
KCNQ4 forms the pore of a voltage-gated potassium (Kv) channel. Four pore-forming subunits assemble as a tetramer. The channel promotes the outflow of potassium ions during the repolarisation phase of the action potential, which contributes to setting the membrane potential of excitable cells. It conducts a slowly activating and deactivating current, and the current often shows some inward rectification at positive potentials. In vitro, the channel may also be permeable to other cations, with a decreasing order of affinity of K(+) = Rb(+) > Cs(+) > Na(+).
The KCNQ4 protein is a member of the potassium channel family, in the KQT subfamily (TC 1.A.1.15), and the Kv7.4/KCNQ4 sub-subfamily. Its activity is thought to be important in regulating the excitability of sensory cells in the cochlea, and it is needed for normal inner ear function, including the sensory perception of sound. The encoded protein can form a homomultimeric channel, or possibly a heteromultimeric channel together with the protein encoded by the KCNQ3 gene. The current is inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, an anti-convulsant drug. UniProt places the channel at the basal cell membrane.
The KCNQ4 gene belongs to the HGUC group of potassium voltage-gated channels. Its earlier names were potassium voltage-gated channel, KQT-like subfamily, member 4. Defects in the gene cause nonsyndromic sensorineural deafness type 2 (DFNA2), an autosomal dominant form of progressive hearing loss, which explains the DFNA2 alias. Two transcript variants encoding different isoforms have been described. Mouse and rat both have a Kcnq4 ortholog, which supports the use of rodent models in hearing and channel research.
KCNQ4 regulates the excitability of sensory cells in the cochlea and is important for the perception of sound.
Defects in KCNQ4 cause DFNA2, an autosomal dominant form of progressive nonsyndromic sensorineural deafness.
The channel carries a slowly activating, slowly deactivating current that contributes to action potential repolarisation and membrane potential control.
KCNQ4 current is inhibited by M1 muscarinic receptors and activated by retigabine, making it a model for studying Kv7 modulation.
KCNQ4 is the pore-forming subunit of a voltage-gated potassium channel. By allowing potassium efflux during action potential repolarisation, it helps regulate membrane potential and the excitability of sensory cells in the cochlea, and it supports normal hearing.
KCNQ4 is also called Kv7.4 and DFNA2. Its UniProt name is potassium voltage-gated channel subfamily KQT member 4. Earlier HGNC names described it as a KQT-like subfamily, member 4 channel. Two transcript variants encoding different isoforms are known.
Yes. Defects in the KCNQ4 gene cause DFNA2, an autosomal dominant, progressive nonsyndromic sensorineural hearing loss. Orthologs named Kcnq4 exist in mouse and rat; check the datasheet of any product for its validated reactivity.
Other Kv7 potassium channels and the muscarinic receptor that modulates KCNQ4 current, where Assay Genie has pages.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P56696; product specifications from Assay Genie datasheets.